$アキレス・セラピューティクス(ACHL.US)$Achilles Therapeutics Provides Interim Phase 1/2a Update on Clonal Neoantigen Reactive T Cells In Advanced NSCLC And Melanoma Including First Patients Dosed With Enhanced Host Conditioning Moomoo 24/7· 1 min ago Achilles Therapeutics (ACHL.Improved VELOS manufacturing process delivering higher cNeT doses. Protocols updated to evaluate the benefit of enhanced host conditioning, with further data expected in 2H 2024. First three patients dosed in CHIRON and T...
$アキレス・セラピューティクス(ACHL.US)$Looking for a in! Participating in 10th Annual Immuno-Oncology 360 Conference on February 29! Also expecting Phase data before end of 1st Q? They also have 140M on hand and at current burn rate, should be plenty of money to get them well into 2025
Large blocks purchased yesterday 🤔 around 5.50. Good action at close. Could be a head fake, waiting for breakout over 5.73 to confirm overall trend reversal. Entry(higher risk): 5.50-5.55 Swing Entry (lower risk): 5.73 Targets: T1- 5.73. T2- 5.93 T3- 6.20 T4- 7.07 SL-5.37 $アキレス・セラピューティクス(ACHL.US)$
1
1
報告
PocketChangeスレ主 :
Well, head fake it is. No entry did not surpass 5.73 w vol. Remember, wait for confirmation of a trend reversal. Even if you miss out on 3-5% It’s worth waiting short term or long term on any type of trade.
アキレス・セラピューティクスに関するコメント
Moomoo 24/7· 1 min ago
Achilles Therapeutics (ACHL.Improved VELOS manufacturing process delivering higher cNeT doses.
Protocols updated to evaluate the benefit of enhanced host conditioning, with further data expected in 2H 2024.
First three patients dosed in CHIRON and T...
Watchlist.
$ザイバーサ セラピューティクス(ZVSA.US)$ $Roma Green Finance(ROMA.US)$ $ベル(VERU.US)$ $アキレス・セラピューティクス(ACHL.US)$ $Gaxos.ai(GXAI.US)$ $アプライド セラピューティクス(APLT.US)$ $ソンダー ホールディングス(SOND.US)$
📊⚡️📊
Entry(higher risk): 5.50-5.55
Swing Entry (lower risk): 5.73
Targets: T1- 5.73.
T2- 5.93
T3- 6.20
T4- 7.07
SL-5.37
$アキレス・セラピューティクス(ACHL.US)$
2. $リコール システムズ(REKR.US)$ has a gap up in play. 7.15-10.50.
3. $Osmotica Pharmaceuticals(OSMT.US)$ has rebounded off its support.Has two big gap ups in play for the next week. 1.65-3.01
4. $アキレス・セラピューティクス(ACHL.US)$ starting back up to its recent high. 5.60-8.86
5. $アルパイン4 ホールディングス(ALPP.US)$ working toward its IPO price. 3.04-4.62.
6. $ヴェリセル(VCEL.US)$ has 3 gap ups coming. 42.33-51.00
まだコメントはありません